Join Jackie Hunter CBE FMedSci at the Royal Academy of Engineering where she will present her vision for how cutting-edge technologies have the potential to change communities around the world.
Session: Transformational technology: How will new innovations revolutionise our world?
Introductory remarks by Dr Keoki Jackson, Chief Technology Officer, Lockheed Martin and invited speakers:
Dr Gill Pratt (via video), Founding CEO of the Toyota Research Institute
Rob Meyerson, Space engineer and former CEO at Blue Origin
Sir Mark Walport FRS FMedSci, CEO, UK Research & Innovation
Professor Jackie Hunter CBE FMedSci
Jackie Hunter is Chief Executive, Clinical Programmes & Strategic Relationships. She held senior positions at global pharmaceutical organisations including GSK, Proximagen and OI Pharma Partners before joining BenevolentAI as a Director in 2016. She brings vast academic and business experience in the biomedical and pharmaceutical sectors. She directs the application of BenevolentAI’s technology for clinical development and gives the company the insight it needs to operate its unique business model – one which sees it not only researching, but also developing the blueprint for new drugs.